Cassava Sciences Inc.

285 articles about Cassava Sciences Inc.

• Pain Therapeutics Modifies Strategic Alliance With King Pharmaceuticals®, Inc. for REMOXY(R) in Europe

  6/28/2010

• Pain Therapeutics to Present at Needham Healthcare Conference

  6/4/2010

• Pain Therapeutics to Present at Jefferies Healthcare Conference

  6/3/2010

• Pain Therapeutics Reports First Quarter 2010 Financial Results

  4/28/2010

• Pain Therapeutics Announces Encouraging Clinical Data With a New Drug for Skin Cancer

  3/23/2010

• Pain Therapeutics to Present at Cowen and Company Health Care Conference

  3/3/2010

• Pain Therapeutics Announces 2009 Financial Results, Outlines Business Priorities

  1/28/2010

• Pain Therapeutics to Present at the Credit Suisse Healthcare Conference

  11/4/2009

• Pain Therapeutics Reports Third Quarter 2009 Results

  10/29/2009

• Pain Therapeutics to Present At UBS Global Life Sciences Conference

  9/16/2009

• Pain Therapeutics Reviews Mid-Year Progress, Reports Second Quarter 2009 Financial Results

  8/4/2009

• King Pharmaceuticals®, Inc., Pain Therapeutics May Refile Remoxy in 2010

  7/7/2009

• Pain Therapeutics Invited to Present At Two Investor Conferences

  6/4/2009

• Pain Therapeutics Initiates Clinical Study in Cancer Patients

  5/5/2009

• Pain Therapeutics Announces First Quarter 2009 Financial Results

  4/30/2009

• Pain Therapeutics to Present At the Barclays Capital Healthcare Conference

  3/6/2009

• Pain Therapeutics Announces Year-End 2008 Financial Results, Outlines 2009 Business Priorities

  2/5/2009

• Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY(R): NDA is Not Approved

  12/11/2008

• Pain Therapeutics to Present At the Piper Jaffray Health Care Conference

  11/25/2008

• FDA Panel Mixed on King Pharmaceuticals®, Inc., Pain Therapeutics Drug; FDA Scheduled to Act By December 10 Under Six-Month Priority Review

  11/14/2008